Cross-site validation of lung cancer diagnosis by electronic nose with deep learning: a multicenter prospective study

被引:2
作者
Lee, Meng-Rui [1 ,2 ]
Kao, Mu-Hsiang [3 ]
Hsieh, Ya-Chu [3 ]
Sun, Min [3 ]
Tang, Kea-Tiong [3 ]
Wang, Jann-Yuan [1 ]
Ho, Chao-Chi [1 ]
Shih, Jin-Yuan [1 ]
Yu, Chong-Jen [1 ,2 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Internal Med, Hsinchu, Taiwan
[3] Natl Tsing Hua Univ, Dept Elect Engn, 101 Sec 2,Kuang Fu Rd, Hsinchu 30013, Taiwan
关键词
Electronic nose; Cross-site validation; Lung cancer; Breathprint; Deep learning; Data augmentation; VOLATILE ORGANIC-COMPOUNDS; SMOKING; BREATH; ARRAY;
D O I
10.1186/s12931-024-02840-z
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Although electronic nose (eNose) has been intensively investigated for diagnosing lung cancer, cross-site validation remains a major obstacle to be overcome and no studies have yet been performed.Methods Patients with lung cancer, as well as healthy control and diseased control groups, were prospectively recruited from two referral centers between 2019 and 2022. Deep learning models for detecting lung cancer with eNose breathprint were developed using training cohort from one site and then tested on cohort from the other site. Semi-Supervised Domain-Generalized (Semi-DG) Augmentation (SDA) and Noise-Shift Augmentation (NSA) methods with or without fine-tuning was applied to improve performance.Results In this study, 231 participants were enrolled, comprising a training/validation cohort of 168 individuals (90 with lung cancer, 16 healthy controls, and 62 diseased controls) and a test cohort of 63 individuals (28 with lung cancer, 10 healthy controls, and 25 diseased controls). The model has satisfactory results in the validation cohort from the same hospital while directly applying the trained model to the test cohort yielded suboptimal results (AUC, 0.61, 95% CI: 0.47 & horbar;0.76). The performance improved after applying data augmentation methods in the training cohort (SDA, AUC: 0.89 [0.81 & horbar;0.97]; NSA, AUC:0.90 [0.89 & horbar;1.00]). Additionally, after applying fine-tuning methods, the performance further improved (SDA plus fine-tuning, AUC:0.95 [0.89 & horbar;1.00]; NSA plus fine-tuning, AUC:0.95 [0.90 & horbar;1.00]).Conclusion Our study revealed that deep learning models developed for eNose breathprint can achieve cross-site validation with data augmentation and fine-tuning. Accordingly, eNose breathprints emerge as a convenient, non-invasive, and potentially generalizable solution for lung cancer detection.Clinical trial registration This study is not a clinical trial and was therefore not registered.
引用
收藏
页数:11
相关论文
共 38 条
  • [1] INNOVATIVE TECHNIQUES Effects of dietary nutrients on volatile breath metabolites
    Ajibola, Olawunmi A.
    Smith, David
    Spanel, Patrik
    Ferns, Gordon A. A.
    [J]. JOURNAL OF NUTRITIONAL SCIENCE, 2013, 2 : 1 - 15
  • [2] Anticuando MK, 2022, 13 INT C COMP COMM N, P1
  • [3] Inhaled today, not gone tomorrow: pharmacokinetics and environmental exposure of volatiles in exhaled breath
    Beauchamp, J.
    [J]. JOURNAL OF BREATH RESEARCH, 2011, 5 (03)
  • [4] Detection of COPD and Lung Cancer with electronic nose using ensemble learning methods
    Binson, V. A.
    Subramoniam, M.
    Mathew, Luke
    [J]. CLINICA CHIMICA ACTA, 2021, 523 : 231 - 238
  • [5] A review of the management of elderly patients with non-small-cell lung cancer
    Blanco, R.
    Maestu, I.
    de la Torre, M. G.
    Cassinello, A.
    Nunez, I.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (03) : 451 - 463
  • [6] The influence of lifestyle factors on fecal volatile organic compound composition as measured by an electronic nose
    Bosch, Sofie
    Lemmen, Jesse P. M.
    Menezes, Renee
    van der Hulst, Rene
    Kuijvenhoven, Johan
    Stokkers, Pieter C. F.
    de Meiji, Tim G. J.
    de Boer, Nanne K. H.
    [J]. JOURNAL OF BREATH RESEARCH, 2019, 13 (04)
  • [7] Gas Recognition in E-Nose System: A Review
    Chen, Hong
    Huo, Dexuan
    Zhang, Jilin
    [J]. IEEE TRANSACTIONS ON BIOMEDICAL CIRCUITS AND SYSTEMS, 2022, 16 (02) : 169 - 184
  • [8] Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the US
    Choi, Eunji
    Ding, Victoria Y.
    Luo, Sophia J.
    ten Haaf, Kevin
    Wu, Julie T.
    Aredo, Jacqueline V.
    Wilkens, Lynne R.
    Freedman, Neal D.
    Backhus, Leah M.
    Leung, Ann N.
    Meza, Rafael
    Lui, Natalie S.
    Haiman, Christopher A.
    Park, Sung-Shim Lani
    Le Marchand, Loic
    Neal, Joel W.
    Cheng, Iona
    Wakelee, Heather A.
    Tammemaegi, Martin C.
    Han, Summer S.
    [J]. JAMA ONCOLOGY, 2023, 9 (12) : 1640 - 1648
  • [9] Prospective Detection of Early Lung Cancer in Patients With COPD in Regular Care by Electronic Nose Analysis of Exhaled Breath
    de Vries, Rianne
    Farzan, Niloufar
    Fabius, Timon
    De Jongh, Frans H. C.
    Jak, Patrick M. C.
    Haarman, Eric G.
    Snoey, Erik
    Veen, Johannes C. C. M. In'T
    Dagelet, Yennece W. F.
    Maitland-Van Der Zee, Anke-Hilse
    Lucas, Annelies
    Van Den Heuvel, Michel M.
    Wolf-Lansdorf, Marguerite
    Muller, Mirte
    Baas, Paul
    Sterk, Peter J.
    [J]. CHEST, 2023, 164 (05) : 1315 - 1324
  • [10] The Eighth Edition Lung Cancer Stage Classification
    Detterbeck, Frank C.
    Boffa, Daniel J.
    Kim, Anthony W.
    Tanoue, Lynn T.
    [J]. CHEST, 2017, 151 (01) : 193 - 203